NCT00231439View on ClinicalTrials.gov

Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

July 31, 2004

Conditions
Post-Polio Syndrome
Interventions
DRUG

IvIg

All Listed Sponsors
lead

Haukeland University Hospital

OTHER

NCT00231439 - Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) | Biotech Hunter | Biotech Hunter